By synthesizing evidence from RCTs and real-world studies, we seek to provide a comprehensive assessment of clinical, renal, and hemodynamic outcomes, thereby informing clinicians and policymakers on the role of renin inhibitors in contemporary hypertension management. This evidence concerns the gene REN and Hypertension.